 Mark Erickson
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 51 | 2025 | 224 | 9.320 |
Why?
| | Spinal Fusion | 42 | 2026 | 260 | 8.440 |
Why?
| | Neuromuscular Diseases | 6 | 2025 | 146 | 2.170 |
Why?
| | Surgical Wound Infection | 10 | 2026 | 316 | 1.800 |
Why?
| | Thoracic Vertebrae | 14 | 2024 | 79 | 1.600 |
Why?
| | Internal Fixators | 5 | 2015 | 32 | 1.310 |
Why?
| | Kyphosis | 8 | 2024 | 37 | 1.230 |
Why?
| | Bone Screws | 8 | 2024 | 110 | 1.200 |
Why?
| | Spine | 11 | 2022 | 182 | 1.170 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2025 | 32 | 1.100 |
Why?
| | Lumbar Vertebrae | 6 | 2015 | 252 | 1.070 |
Why?
| | Radiography | 14 | 2024 | 845 | 0.990 |
Why?
| | Arthralgia | 1 | 2025 | 61 | 0.870 |
Why?
| | Body Height | 1 | 2025 | 202 | 0.840 |
Why?
| | Cerebral Palsy | 2 | 2025 | 132 | 0.810 |
Why?
| | Child | 48 | 2026 | 22657 | 0.730 |
Why?
| | Retrospective Studies | 39 | 2026 | 17101 | 0.690 |
Why?
| | Musculoskeletal Diseases | 2 | 2019 | 90 | 0.670 |
Why?
| | Patient Care Team | 4 | 2026 | 689 | 0.670 |
Why?
| | Adolescent | 39 | 2026 | 22453 | 0.630 |
Why?
| | Fitness Trackers | 1 | 2019 | 16 | 0.610 |
Why?
| | Postoperative Complications | 10 | 2024 | 2920 | 0.600 |
Why?
| | Musculoskeletal System | 1 | 2019 | 54 | 0.580 |
Why?
| | Quality of Life | 9 | 2025 | 3192 | 0.580 |
Why?
| | Follow-Up Studies | 13 | 2025 | 5417 | 0.550 |
Why?
| | Vancomycin | 1 | 2018 | 93 | 0.530 |
Why?
| | Treatment Outcome | 27 | 2025 | 11695 | 0.510 |
Why?
| | Orthopedics | 1 | 2019 | 169 | 0.500 |
Why?
| | Spinal Diseases | 2 | 2017 | 50 | 0.480 |
Why?
| | Propionibacterium acnes | 1 | 2015 | 10 | 0.450 |
Why?
| | Reoperation | 2 | 2016 | 631 | 0.450 |
Why?
| | Intervertebral Disc | 1 | 2015 | 36 | 0.450 |
Why?
| | Humans | 74 | 2026 | 144957 | 0.440 |
Why?
| | Ribs | 2 | 2025 | 35 | 0.430 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 54 | 0.420 |
Why?
| | Male | 45 | 2026 | 72406 | 0.420 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2015 | 70 | 0.420 |
Why?
| | Prosthesis-Related Infections | 1 | 2015 | 99 | 0.410 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 390 | 0.410 |
Why?
| | Female | 46 | 2026 | 78376 | 0.390 |
Why?
| | Sutures | 1 | 2013 | 64 | 0.390 |
Why?
| | Home Nursing | 1 | 2013 | 23 | 0.390 |
Why?
| | Suture Techniques | 1 | 2013 | 131 | 0.380 |
Why?
| | Soft Tissue Injuries | 1 | 2013 | 34 | 0.370 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 19 | 0.370 |
Why?
| | Casts, Surgical | 1 | 2012 | 35 | 0.370 |
Why?
| | Patient Satisfaction | 3 | 2025 | 705 | 0.370 |
Why?
| | Bupivacaine | 1 | 2012 | 38 | 0.370 |
Why?
| | Equipment Failure | 1 | 2013 | 115 | 0.370 |
Why?
| | Humeral Fractures | 1 | 2012 | 46 | 0.360 |
Why?
| | Amides | 1 | 2012 | 101 | 0.360 |
Why?
| | Fracture Fixation | 1 | 2012 | 79 | 0.350 |
Why?
| | Metals | 1 | 2013 | 142 | 0.350 |
Why?
| | Preoperative Care | 2 | 2011 | 380 | 0.340 |
Why?
| | Orthopedic Procedures | 2 | 2018 | 243 | 0.320 |
Why?
| | Bone Nails | 2 | 2012 | 62 | 0.300 |
Why?
| | Risk Factors | 10 | 2026 | 10792 | 0.280 |
Why?
| | Blood Loss, Surgical | 2 | 2021 | 112 | 0.280 |
Why?
| | Prostheses and Implants | 2 | 2025 | 141 | 0.260 |
Why?
| | Diskectomy | 1 | 2007 | 24 | 0.260 |
Why?
| | Decompression, Surgical | 2 | 2007 | 117 | 0.260 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2007 | 80 | 0.250 |
Why?
| | Anti-Bacterial Agents | 4 | 2018 | 1915 | 0.240 |
Why?
| | Cervical Vertebrae | 1 | 2007 | 158 | 0.230 |
Why?
| | Caregivers | 2 | 2022 | 1049 | 0.230 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2025 | 39 | 0.230 |
Why?
| | Evoked Potentials, Motor | 1 | 2025 | 50 | 0.230 |
Why?
| | Bone Lengthening | 1 | 2025 | 8 | 0.230 |
Why?
| | Hospitals, Pediatric | 5 | 2017 | 557 | 0.220 |
Why?
| | Titanium | 1 | 2025 | 81 | 0.210 |
Why?
| | Prospective Studies | 13 | 2023 | 7997 | 0.210 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 10 | 0.200 |
Why?
| | Pedicle Screws | 1 | 2024 | 21 | 0.200 |
Why?
| | Scurvy | 1 | 2024 | 17 | 0.200 |
Why?
| | Practice Guidelines as Topic | 4 | 2017 | 1563 | 0.190 |
Why?
| | Child, Preschool | 9 | 2025 | 11799 | 0.190 |
Why?
| | Pain | 3 | 2024 | 782 | 0.180 |
Why?
| | Osteotomy | 4 | 2023 | 127 | 0.180 |
Why?
| | Algorithms | 1 | 2010 | 1839 | 0.180 |
Why?
| | Muscle Relaxants, Central | 1 | 2022 | 14 | 0.180 |
Why?
| | Pelvic Bones | 1 | 2004 | 135 | 0.180 |
Why?
| | Parents | 3 | 2025 | 1403 | 0.180 |
Why?
| | Cohort Studies | 5 | 2023 | 5965 | 0.180 |
Why?
| | Neural Tube Defects | 1 | 2022 | 65 | 0.170 |
Why?
| | Laminectomy | 1 | 2021 | 31 | 0.170 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 16 | 0.170 |
Why?
| | Robotic Surgical Procedures | 1 | 2024 | 182 | 0.170 |
Why?
| | Pain Measurement | 3 | 2017 | 555 | 0.160 |
Why?
| | Thoracoplasty | 1 | 2020 | 2 | 0.160 |
Why?
| | Surveys and Questionnaires | 9 | 2025 | 6053 | 0.160 |
Why?
| | Age of Onset | 3 | 2025 | 551 | 0.160 |
Why?
| | Postoperative Care | 2 | 2015 | 288 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 489 | 0.160 |
Why?
| | Length of Stay | 4 | 2017 | 1337 | 0.150 |
Why?
| | Scheuermann Disease | 1 | 2019 | 1 | 0.150 |
Why?
| | Bone Wires | 2 | 2011 | 17 | 0.140 |
Why?
| | Analgesics, Opioid | 2 | 2017 | 1143 | 0.140 |
Why?
| | Administration, Topical | 1 | 2018 | 150 | 0.140 |
Why?
| | Mental Health | 1 | 2025 | 792 | 0.140 |
Why?
| | Patient Preference | 1 | 2020 | 225 | 0.130 |
Why?
| | Osteogenesis Imperfecta | 1 | 2017 | 14 | 0.130 |
Why?
| | Incidence | 3 | 2019 | 2883 | 0.130 |
Why?
| | Drug Utilization Review | 1 | 2017 | 61 | 0.130 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 129 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2019 | 245 | 0.120 |
Why?
| | Surgeons | 1 | 2021 | 340 | 0.120 |
Why?
| | Clinical Protocols | 1 | 2018 | 282 | 0.120 |
Why?
| | Patient Participation | 1 | 2020 | 433 | 0.120 |
Why?
| | Morphine | 1 | 2017 | 171 | 0.120 |
Why?
| | Comorbidity | 2 | 2011 | 1660 | 0.120 |
Why?
| | Radiologic Health | 1 | 2015 | 4 | 0.110 |
Why?
| | Debridement | 1 | 2015 | 86 | 0.110 |
Why?
| | Fluoroscopy | 1 | 2015 | 176 | 0.110 |
Why?
| | Equipment Failure Analysis | 1 | 2015 | 128 | 0.110 |
Why?
| | Cost Savings | 1 | 2015 | 86 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 529 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 966 | 0.100 |
Why?
| | Informed Consent | 1 | 2016 | 198 | 0.100 |
Why?
| | Patient Readmission | 2 | 2017 | 759 | 0.100 |
Why?
| | Patient Compliance | 1 | 2018 | 589 | 0.100 |
Why?
| | Device Removal | 1 | 2015 | 143 | 0.100 |
Why?
| | Hospital Charges | 1 | 2013 | 46 | 0.100 |
Why?
| | Blood Transfusion | 1 | 2017 | 405 | 0.100 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1721 | 0.100 |
Why?
| | Asepsis | 1 | 2013 | 3 | 0.100 |
Why?
| | Pain Management | 1 | 2017 | 405 | 0.100 |
Why?
| | Syringomyelia | 2 | 2003 | 12 | 0.100 |
Why?
| | Drug Administration Schedule | 2 | 2012 | 783 | 0.100 |
Why?
| | Osteolysis | 1 | 2013 | 16 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2017 | 589 | 0.090 |
Why?
| | Off-Label Use | 1 | 2013 | 51 | 0.090 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 58 | 0.090 |
Why?
| | Quality Improvement | 3 | 2018 | 1291 | 0.090 |
Why?
| | Anesthetics, Local | 1 | 2012 | 100 | 0.090 |
Why?
| | Single-Blind Method | 1 | 2012 | 312 | 0.090 |
Why?
| | Risk Assessment | 2 | 2012 | 3676 | 0.090 |
Why?
| | United States | 6 | 2020 | 15988 | 0.090 |
Why?
| | Intraoperative Period | 1 | 2011 | 69 | 0.080 |
Why?
| | Pelvis | 2 | 2024 | 124 | 0.080 |
Why?
| | Elective Surgical Procedures | 1 | 2012 | 201 | 0.080 |
Why?
| | Injury Severity Score | 1 | 2012 | 600 | 0.080 |
Why?
| | Reproducibility of Results | 4 | 2021 | 3415 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2012 | 1311 | 0.080 |
Why?
| | Dibenzothiazepines | 1 | 2009 | 18 | 0.070 |
Why?
| | Nerve Growth Factor | 1 | 2009 | 34 | 0.070 |
Why?
| | Interprofessional Relations | 1 | 2011 | 281 | 0.070 |
Why?
| | Psychomotor Agitation | 1 | 2009 | 70 | 0.070 |
Why?
| | Edema | 1 | 2009 | 124 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2032 | 0.070 |
Why?
| | Spinal Stenosis | 1 | 2007 | 31 | 0.060 |
Why?
| | Radiculopathy | 1 | 2007 | 37 | 0.060 |
Why?
| | Time Factors | 4 | 2025 | 7183 | 0.060 |
Why?
| | Intervertebral Disc Displacement | 1 | 2007 | 41 | 0.060 |
Why?
| | Antipsychotic Agents | 1 | 2009 | 214 | 0.060 |
Why?
| | Delphi Technique | 2 | 2022 | 331 | 0.060 |
Why?
| | Patient Discharge | 1 | 2013 | 983 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3869 | 0.060 |
Why?
| | Consensus | 2 | 2022 | 489 | 0.060 |
Why?
| | Bipolar Disorder | 1 | 2009 | 280 | 0.060 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 424 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2925 | 0.060 |
Why?
| | Qualitative Research | 1 | 2013 | 1671 | 0.060 |
Why?
| | Prevalence | 2 | 2013 | 2836 | 0.050 |
Why?
| | Biomechanical Phenomena | 2 | 2008 | 842 | 0.050 |
Why?
| | Recovery of Function | 2 | 2024 | 710 | 0.050 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2025 | 25 | 0.050 |
Why?
| | Hypotension, Orthostatic | 1 | 2004 | 10 | 0.050 |
Why?
| | Metatarsus | 1 | 2004 | 2 | 0.050 |
Why?
| | Hallux Valgus | 1 | 2004 | 9 | 0.050 |
Why?
| | Critical Care | 1 | 2010 | 697 | 0.050 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2004 | 84 | 0.050 |
Why?
| | Outpatients | 1 | 2007 | 443 | 0.050 |
Why?
| | Lung | 2 | 2020 | 4109 | 0.050 |
Why?
| | Spinal Neoplasms | 1 | 2003 | 37 | 0.050 |
Why?
| | Patient Education as Topic | 2 | 2020 | 780 | 0.050 |
Why?
| | Intraoperative Complications | 1 | 2024 | 156 | 0.050 |
Why?
| | Osteosarcoma | 1 | 2003 | 76 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2010 | 3608 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 180 | 0.050 |
Why?
| | Arnold-Chiari Malformation | 1 | 2002 | 29 | 0.050 |
Why?
| | Infusion Pumps, Implantable | 1 | 2022 | 26 | 0.040 |
Why?
| | Baclofen | 1 | 2022 | 21 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2009 | 1786 | 0.040 |
Why?
| | Neurosurgical Procedures | 1 | 2023 | 202 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3335 | 0.040 |
Why?
| | Forced Expiratory Volume | 2 | 2012 | 449 | 0.040 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 241 | 0.040 |
Why?
| | Infant | 2 | 2013 | 10039 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 405 | 0.040 |
Why?
| | Middle Aged | 5 | 2016 | 35928 | 0.040 |
Why?
| | Depression | 1 | 2009 | 1559 | 0.040 |
Why?
| | Young Adult | 2 | 2013 | 14126 | 0.040 |
Why?
| | Menarche | 1 | 2019 | 52 | 0.040 |
Why?
| | Disease Progression | 3 | 2019 | 2852 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2009 | 1796 | 0.030 |
Why?
| | Pyomyositis | 1 | 2017 | 15 | 0.030 |
Why?
| | Risk Management | 1 | 2018 | 84 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2022 | 460 | 0.030 |
Why?
| | Bloodless Medical and Surgical Procedures | 1 | 2017 | 5 | 0.030 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2017 | 16 | 0.030 |
Why?
| | Braces | 1 | 2017 | 25 | 0.030 |
Why?
| | Ketorolac | 1 | 2017 | 30 | 0.030 |
Why?
| | Injections, Spinal | 1 | 2017 | 121 | 0.030 |
Why?
| | Abscess | 1 | 2017 | 75 | 0.030 |
Why?
| | Observer Variation | 1 | 2018 | 355 | 0.030 |
Why?
| | Organ Size | 1 | 2018 | 463 | 0.030 |
Why?
| | Central Venous Catheters | 1 | 2017 | 53 | 0.030 |
Why?
| | Diphosphonates | 1 | 2017 | 68 | 0.030 |
Why?
| | Medical Records | 1 | 2017 | 189 | 0.030 |
Why?
| | Drug Utilization | 1 | 2017 | 167 | 0.030 |
Why?
| | Bone Density Conservation Agents | 1 | 2017 | 81 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2017 | 170 | 0.030 |
Why?
| | Arthritis, Infectious | 1 | 2017 | 72 | 0.030 |
Why?
| | Operative Time | 1 | 2017 | 175 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2017 | 183 | 0.030 |
Why?
| | Adult | 4 | 2020 | 40506 | 0.030 |
Why?
| | Postoperative Period | 1 | 2017 | 354 | 0.030 |
Why?
| | Fever | 1 | 2017 | 312 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 193 | 0.030 |
Why?
| | Osteomyelitis | 1 | 2017 | 143 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1077 | 0.030 |
Why?
| | Self-Assessment | 1 | 2016 | 74 | 0.030 |
Why?
| | Registries | 1 | 2024 | 2385 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2012 | 1268 | 0.030 |
Why?
| | Perioperative Care | 1 | 2017 | 231 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 1031 | 0.030 |
Why?
| | Comprehension | 1 | 2016 | 180 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2017 | 693 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2017 | 2029 | 0.020 |
Why?
| | Drainage | 1 | 2012 | 185 | 0.020 |
Why?
| | Preoperative Period | 1 | 2011 | 149 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 2438 | 0.020 |
Why?
| | Vital Capacity | 1 | 2011 | 290 | 0.020 |
Why?
| | Health Care Costs | 1 | 2013 | 427 | 0.020 |
Why?
| | Quetiapine Fumarate | 1 | 2009 | 26 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2011 | 547 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5872 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 1003 | 0.020 |
Why?
| | Cadaver | 1 | 2008 | 304 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4564 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1990 | 0.010 |
Why?
| | Databases, Factual | 1 | 2012 | 1486 | 0.010 |
Why?
| | Suicide, Attempted | 1 | 2009 | 422 | 0.010 |
Why?
| | Endpoint Determination | 1 | 2004 | 83 | 0.010 |
Why?
| | Lordosis | 1 | 2003 | 16 | 0.010 |
Why?
| | Survival | 1 | 2003 | 38 | 0.010 |
Why?
| | Stereotaxic Techniques | 1 | 2003 | 42 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2540 | 0.010 |
Why?
| | Mass Screening | 1 | 2011 | 1348 | 0.010 |
Why?
| | Morbidity | 1 | 2003 | 323 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 2004 | 601 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5614 | 0.010 |
Why?
| | Pilot Projects | 1 | 2004 | 1890 | 0.010 |
Why?
| | Blood Pressure | 1 | 2004 | 1769 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 1958 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2003 | 2738 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2004 | 8279 | 0.010 |
Why?
| | Animals | 1 | 2009 | 38109 | 0.000 |
Why?
| | Aged | 1 | 2004 | 25947 | 0.000 |
Why?
|
|
Erickson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|